Related Experiment Videos
Autoimmunity in congenital rubella syndrome
The Journal of Pediatrics
|March 1, 1984
Summary
Deaf adolescents with congenital rubella syndrome show higher rates of thyroid autoimmunity compared to controls. Screening for thyroid dysfunction is recommended for all congenital rubella syndrome patients.
Area of Science:
- Immunology
- Endocrinology
- Pediatrics
Background:
- Congenital rubella syndrome (CRS) is a viral illness with potential long-term health consequences.
- Autoimmune conditions, particularly thyroid autoimmunity, are increasingly recognized in individuals with CRS.
- Understanding the prevalence and associations of organ-specific antibodies in CRS is crucial for early diagnosis and management.
Purpose of the Study:
- To investigate the prevalence of organ-specific autoantibodies in deaf adolescents with CRS.
- To compare antibody levels between CRS patients and age-matched deaf controls.
- To assess the association between organ-specific antibodies and thyroid dysfunction in this population.
Main Methods:
- Evaluation of 201 deaf adolescents with CRS and 83 deaf controls for organ-specific antibodies (thyroid microsomes, thyroglobulin, islet cells, adrenal cortex, gastric parietal cells).
- Serological testing for antibody presence.
- Assessment of thyroid gland dysfunction using serum TSH concentrations.
Main Results:
- Higher prevalence of thyroid microsomal or thyroglobulin antibodies in the CRS group (23.3%) compared to controls (12.0%).
- Thyroid dysfunction (elevated TSH) was observed in a significant proportion of subjects with thyroid autoimmunity in both groups.
- Parietal cell antibodies were detected in both groups, with a higher frequency in those with thyroid autoimmunity.
Conclusions:
- Patients with congenital rubella syndrome exhibit an increased risk of developing thyroid autoimmunity.
- Routine screening for thyroid autoimmunity and subsequent evaluation for thyroid dysfunction are recommended for all individuals with CRS.
- Further research into the immunopathogenesis of CRS-associated autoimmunity is warranted.